Drug Development
-
Labor L+S AG, Symbiosis form alliance
Labor L+S AG, Bad Bocklet and Symbiosis, the newly created business division of Biopharm GmbH, Heidelberg, announced that they have entered into an exclusive business alliance.
Drug Development | 16 May 2012
-
ACM Global Central Laboratory establishes Mumbai-based subsidiary
ACM Global Central Lab has advanced its hybrid central lab model in Mumbai with an operational facility dedicated to manage clinical trials testing in India and provide study support throughout Asia Pacific.
Drug Development | 15 May 2012
-
UCB, Domainex Collaborates
Working together, the two companies have developed an experimental system to study the three-dimensional structure of Mitogen-activated protein kinase kinase (MAPKK, also known as MEK), a protein which is over-active in many human cancers.
Drug Development | 10 May 2012
-
Siro Clinpharm appoints chief executive officer
Siro Clinpharm announced the appointment of Gopakumar Menon as chief executive officer.
Drug Development | 09 May 2012
-
Bayer HealthCare, Tsinghua University in partnership
Both partners signed a new strategic agreement to collaborate in the area of biomedical sciences over the next three years.
Drug Development | 07 May 2012
-
AB SCIEX opens scientific hub in Singapore
AB SCIEX announced that it has opened its new APAC Regional Application & Training Centre in Biopolis. This move fortifies the company’s focus on Singapore as a base for supporting a rising concentration of scientists across Asia Pacific using mass spectrometry.
Drug Development | 26 April 2012
-
Quintiles celebrates 30th anniversary
In 2012, Quintiles marks the 30-year anniversary of the company’s incorporation, transforming from a small statistical consulting firm housed in a university campus trailer to the world’s largest biopharmaceutical services company with 25,000 employees and offices in 60-plus countries.
Drug Development | 25 April 2012
-
Erasmus Medical Center selects Agilent solutions
Agilent Technologies announced that Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part of the Erasmus Rucphen Family study to identify genetic risk factors for some complex genetic disorders.
Drug Development | 23 April 2012
-
Quintiles, Biofund to expand clinical development capabilities in Russia
Russian venture company (RVC), Biofund, and Quintiles announced an agreement to support expansion of clinical development services within the Russian Federation, the world’s ninth most populous country.
Drug Development | 13 April 2012
-
Life Technologies appoints head of global research and development
Life Technologies announced that Alan B Sachs, MD, PhD, former vice president, exploratory and translational sciences for Merck Research Laboratories, has joined the company as head of global research and development.
Drug Development | 11 April 2012
